This inventor holds 10 USPTO granted patents and 5 published patent applications and 6 EPO patents. Top assignees: Janssen Pharmaceutica Nv, Other. Active years: 2021-2026.
Location History:
- Newport Beach, CA (US) (2022)
- San Diego, CA (US) (2021 - 2024)
Company Filing History:
9 out of 2,099 
1 out of 834,411 Years Active: 2021-2026
Title: The Innovative Contributions of Connor L Martin
Introduction
Connor L Martin is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate IL-17. With a total of nine patents to his name, Martin's work is recognized for its potential impact on treating various IL-17 mediated conditions.
Latest Patents
Among his latest patents, Martin has developed compounds known as Imidazopyridazines, which serve as modulators of IL-17. The present application discloses compounds having specific formulas, as well as methods for making and using these compounds to treat or ameliorate IL-17 mediated syndromes, disorders, and diseases. This innovative approach highlights the potential for new therapeutic options in the pharmaceutical landscape.
Career Highlights
Throughout his career, Connor L Martin has worked with notable companies, including Janssen Pharmaceutica NV. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to drive innovation in drug development.
Collaborations
Martin has collaborated with esteemed colleagues such as Steven D Goldberg and Xiaohua Xue. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Connor L Martin's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his role as a leading inventor. His work continues to pave the way for advancements in treating IL-17 mediated conditions.